Lifeboat Foundation

Medical workers have been looking for signs of illness before clearing flights for takeoff.

Under the FDA’s Expanded Access program, more folks can legally get access to medical-grade MDMA for psychotherapy.

A new type of killer T-cell could serve as “one-size-fits-all” cancer therapy.

Researchers at Cardiff University in Wales discovered a different kind of T-cell receptor (TCR)—one that recognizes and kills most human cancer cells while ignoring healthy ones.

Continue reading “Killer T-Cell Discovery Could Mean ‘Universal’ Cancer Treatment” »

Terahertz radiation is used for security checks at airports, for medical examinations and also for quality checks in industry. However, radiation in the terahertz range is extremely difficult to generate. Scientists at TU Wien have now succeeded in developing a terahertz radiation source that breaks several records: it is extremely efficient, and its spectrum is very broad—it generates different wavelengths from the entire terahertz range. This opens up the possibility of creating short radiation pulses with extremely high radiation intensity. The new terahertz technology has now been presented in the journal Nature Communications.

The “Terahertz Gap” Between Lasers and Antennas

“Terahertz radiation has very useful properties,” says Claudia Gollner from the Institute of Photonics at TU Wien. “It can easily penetrate many materials, but unlike X-rays, it is harmless because it is not ionizing radiation.”

This means it will significantly harder to contain.

The man, in his 30s, is in stable condition at Providence Regional Medical Center in Everett, Wash. Officials said they are monitoring him there out of an abundance of caution, not because he is seriously ill. The man arrived in the United States last week, before federal health officials began screening travelers from the central Chinese city of Wuhan at Los Angeles, San Francisco and New York’s John F. Kennedy international airports, the first such effort since the 2014 Ebola outbreak.

Read more.

“https://www.cardiff.ac.uk/news/view/1749599-discovery-of-new…r-therapy.”

Researchers at Cardiff University have discovered a new type of killer T-cell that offers hope of a “one-size-fits-all” cancer therapy.

T-cell therapies for cancer — where immune cells are removed, modified and returned to the patient’s blood to seek and destroy cancer cells — are the latest paradigm in cancer treatments.

Continue reading “Discovery of new T-cell raises prospect of ‘universal’ cancer therapy” »

https://www.youtube.com/watch?v=qMGAane9QVc

AgeX Therapeutics Inc (NYSEAMERICAN: AGE) CEO Michael West sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Alameda, California biotechnology company is developing a cell therapy treatment for metabolic disorders such as Type 2 diabetes.